Effect of roflumilast on lung function and exacerbations in patients with chronic obstructive pulmonary disease: Results of a one year study

被引：0
|
作者：
Calverley, PMA
Fabbri, LM
Teichmann, P
Bredenbroeker, D
机构：
[1] Univ Hosp Aintree, Liverpool, Merseyside, England
[2] Univ Modena, I-41100 Modena, Italy
[3] ALTANA Pharma AG, Constance, Germany
来源：
THORAX | 2005年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：II42 / II42
页数：1
相关论文
共 50 条
  • [21] Lung Function Trajectories Leading to Chronic Obstructive Pulmonary Disease as Predictors of Exacerbations and Mortality
    Marott, Jacob Louis
    Ingebrigtsen, Truls Sylvan
    Colak, Yunus
    Vestbo, Jorgen
    Lange, Peter
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 202 (02) : 210 - 218
  • [22] Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease
    Dransfield, Mark T.
    Kunisaki, Ken M.
    Strand, Matthew J.
    Anzueto, Antonio
    Bhatt, Surya P.
    Bowler, Russell P.
    Criner, Gerard J.
    Curtis, Jeffrey L.
    Hanania, Nicola A.
    Nath, Hrudaya
    Putcha, Nirupama
    Roark, Sarah E.
    Wan, Emily S.
    Washko, George R.
    Wells, J. Michael
    Wendt, Christine H.
    Make, Barry J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195 (03) : 324 - 330
  • [23] Roflumilast in severely ill patients with chronic obstructive pulmonary disease with frequent exacerbations: real-life outcomes
    Alispahic, Imane Achir
    Sorensen, Rikke
    Eklof, Josefin
    Sivapalan, Pradeesh
    Lokke, Anders
    Seersholm, Niels
    Vestergaard, Jakob Hedemark
    Bergsoe, Christina Marisa
    Jensen, Jens-Ulrik Staehr
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [24] Impact of roflumilast on dyspnea and lung function in patients with chronic obstructive pulmonary disease: a pooled analysis of four clinical trials
    Rennard, Stephen I.
    Sun, Shawn X.
    Tourkodimitris, Stavros
    Rowe, Paul
    Goehring, Udo M.
    Calverley, Peter M. A.
    QUALITY OF LIFE RESEARCH, 2013, 22
  • [25] Roflumilast in the management of chronic obstructive pulmonary disease
    Lipari, Melissa
    Benipal, Harpreet
    Kale-Pradhan, Pramodini
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2013, 70 (23) : 2087 - 2095
  • [26] Roflumilast for chronic obstructive pulmonary disease - Reply
    Rabe, KF
    LANCET, 2005, 366 (9500): : 1846 - 1847
  • [27] Results of Lung Transplantation in Patients With Chronic Obstructive Pulmonary Disease
    Cano, J. R.
    Algar, F. J.
    Cerezo, F.
    Moreno, P.
    Espinosa, D.
    Alvarez, A.
    Baamonde, C.
    Santos, F.
    Salvatierra, A.
    TRANSPLANTATION PROCEEDINGS, 2008, 40 (09) : 3073 - 3075
  • [28] Roflumilast (Daliresp) for Chronic Obstructive Pulmonary Disease
    Bazaldua, Oralia V.
    Davidson, Dewayne A.
    Babb, Franklyn C.
    AMERICAN FAMILY PHYSICIAN, 2014, 89 (04) : 300 - +
  • [29] Roflumilast for the treatment of chronic obstructive pulmonary disease
    Antoniu, SA
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2006, 7 (05) : 412 - 417
  • [30] Roflumilast for eosinophilic chronic obstructive pulmonary disease?
    Han, MeiLan K.
    LANCET RESPIRATORY MEDICINE, 2018, 6 (11): : 802 - 803
12345